Artios Pharma (private company)
See something wrong or missing? Let us know
Offices:Cambridge
Industry:Health servicesManufacturingPharma
Business model:B2B
Artios Pharma is a British biotech focused on DNA damage response, with a strong pipeline of novel cancer therapies.
Investors:
we tracked 14 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 115M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Artios Pharma
| Name | Criteria | |
|---|---|---|
![]() |
Ability Pharma
63%
|
|
![]() |
Beckley Psytech
63%
|
|
![]() |
Baseimmune
63%
|
|
![]() |
Cytoki Pharma
63%
|
|
![]() |
Abalos Therapeutics
63%
|
|
![]() |
Emergence Therapeutics
63%
|
|
![]() |
SafeHeal
63%
|
|
![]() |
Brenus Pharma
63%
|
|
![]() |
Precirix
63%
|
|
![]() |
Kither Biotech
63%
|
|







Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal